US Executive Officer Management Changes SEC — May 18, 2026

USA Executive & Director Changes

By Gunpowder Editorial ·

44 high priority 44 total filings analysed

Executive Summary

The May 18, 2026, filing batch reveals a broad wave of planned leadership transitions across US equities, with 44 filings covering CEO, CFO, director, and key officer changes. A dominant theme is orderly succession planning, with 15+ filings showing internal promotions or planned retirements (e.g., NextEra Energy, Builders FirstSource, Eagle Bancorp Montana), signaling strong governance and reduced disruption risk.

However, notable health-related disclosures (Wyndham CEO cancer diagnosis) and director resignations (Innoviva, AiXin Life) introduce uncertainty. Shareholder dissent is a recurring pattern: 6 companies (O'Reilly Automotive, Macy's, Marriott Vacations, Ultragenyx, Celcuity, ON Semiconductor) saw >10% against votes on director elections or equity plans, indicating governance friction. Capital allocation signals are mixed—T. Rowe Price reported $1.83T in assets (retirement-heavy), while Flagstar Bank extended CEO tenure amid return to profitability. No aggregate revenue or margin trends are available as filings lack financial statements, but forward-looking data points to key catalysts: FedEx Freight separation, Kyverna CAR-T approval path, and Super Micro consulting transition. Insider activity is limited but notable: Lesaka Technologies granted 1M options to Executive Chairman options at $5.00, and Fennec Pharmaceuticals issued inducement grants at $9.75. The overall risk profile is moderate, with 6 high-risk flags (Powerdyne, Altria, CVS, Aspen Aerogels, Celcuity, Macy's) and 12 positive sentiment signals, suggesting a cautiously bullish for well-governed firms.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K

Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from May 14, 2026.

Investment Signals (12)

  • T. Rowe Price (BULLISH)

    Appointed new President/CIO structure, $1.83T in client assets (67% retirement), positive sentiment on strategy innovation

  • CEO Otting extended through March 2028, $87.1B assets, return to profitability, Co-Presidents appointed

  • New CFO from Ironwood (positive EBITDA track record), lead CAR-T candidate miv-cel approaching potential approval for stiff person syndrome, 325K inducement options

  • Appointed ex-NerdWallet CFO to board, 1,150+ active partners, 141M consumer referrals in 2025, strong tech finance expertise

  • Internal COO promotion (7-year veteran), overseeing 21 offices/1,600 employees, focus on organic growth and M&A

  • 99.7% say-on-pay approval, new LTIP with 800K share pool, CEO target awards $5.7M+

  • Macy's (MIXED)

    Say-on-pay only 78.6% support, director Connelly 77.5% support, equity plan passed 92% but dissent signals governance risk

  • Equity plan approval only 68.9% (31% against), 2.5M new shares, 87% quorum

  • 2026 Stock Plan 24% votes against, director Dalvey 15.4% withheld, advisory pay passed 95.1%

  • Director Yan 26.2M votes against (7.7%), say-on-pay 93.7% pass, Keeton transition extended to Sep 30

  • CEO Ballotti disclosed multiple myeloma diagnosis (favorable prognosis), continuing work with reduced travel, board support [NEUTRAL/BEARISH]

  • SVP Worldwide Sales retired, 6-month consulting at $19,450/month, no disagreement

Risk Flags (10)

  • Director departure flagged as high risk, no details available

  • Altria Group [HIGH RISK]

    Director departure flagged as high risk, no details available

  • CVS Health [HIGH RISK]

    Filing text unavailable for Items 5.02 and 5.07, high risk due to unknown officer changes and shareholder vote outcomes

  • Aspen Aerogels [HIGH RISK]

    Filing metadata lacks specifics on officer changes and vote results, risk of undisclosed leadership shifts could increase uncertainty

  • Celcuity [MEDIUM RISK]

    24% shareholder opposition to 2026 Stock Plan (3M new shares), director Dalvey 15.4% withheld votes, governance friction

  • Macy's [MEDIUM RISK]

    Say-on-pay 78.6% support (43M against), director Connelly 77.5% support, persistent dissent signals compensation misalignment

  • O'Reilly Automotive [MEDIUM RISK]

    Director Murphy 78.2M against votes (13.2%), shareholder proposal on political spending defeated but 44% for, governance divide

  • 22.9M votes against incentive plan (31% of votes cast), significant dilution concern

  • LendingTree [MEDIUM RISK]

    CHRO departure without cause, severance 1x salary + accelerated equity + consulting $10K/month, potential cultural instability

  • Hour Loop [MEDIUM RISK]

    CEO/Chairman and VP/Director (husband/wife) own 94.8% voting power, bonus structure guarantees $100K each regardless of profit targets, governance concern

Opportunities (10)

  • New CFO with commercial expertise, miv-cel approaching potential approval for stiff person syndrome, 325K inducement options align management

  • FedEx Freight Separation (OPPORTUNITY)

    Planned tax-free spin-off, Guy Erwin moving as CAO, Claude Russ interim CAO, potential value unlock

  • Planned FPL CEO transition to Vice Chairman, Scott Bores promoted internally, strong governance and continuity

  • COO-Designate appointed, 40-year industry veteran retiring Dec 2026, orderly transition supports operational stability

  • Nokia President appointed to board, AI Factory Platform strategy, 30+ years scaling tech infrastructure

  • CEO extended, Co-Presidents appointed, $87.1B assets, $8.1B equity, positive trajectory

  • COO promoted to President, CEO remains until retirement, smooth leadership pipeline

  • Healthcare/life sciences expert with Raymond James and Credit Suisse background, standard comp standard

  • Entegris executive chair joins board, audit and governance committees, scalable growth strategy

  • T. Rowe Price/Strategy Innovation (OPPORTUNITY)

    New President and co-CIO structure, $1.83T AUM, retirement-focused stable base

Sector Themes (6)

  • Planned Succession Dominates

    15+ filings show internal promotions or planned retirements (NextEra, Builders FirstSource, Eagle Bancorp, FedEx Freight), indicating strong governance and reduced disruption risk across industrials, energy, and financials.

  • Shareholder Dissent on Compensation/Compensation

    6 companies (O'Reilly, Macy's, Marriott Vacations, Ultragenyx, Celcuity, ON Semi) saw >10% against votes on director elections or equity plans, signaling growing investor scrutiny on pay-for-performance and dilution.

  • Health-Related Director Resignations

    Multiple departures tied to other commitments (Innoviva directors to Syndeio BioSciences, Medtronic exec from MiniMed board), suggesting cross-board resource allocation and potential conflicts of interest.

  • Healthcare Sector Leadership Churn

    5 biotech/pharma filings (Cellectar, 60 Degrees, Kyverna, Ultragenyx, Envoy Medical) with board/CFO changes, reflecting active talent movement as companies advance clinical pipelines toward commercialization.

  • Financial Services Stability Focus

    Banks (Flagstar, Eagle Bancorp) extending CEO tenures and splitting President/CEO roles, emphasizing continuity and operational continuity and risk management in a rising rate environment.

  • Technology Sector Board Refresh

    Tech firms (MediaAlpha, Penguin Solutions, ON Semi) appointing directors with specific finance or AI infrastructure expertise, aligning with strategic pivots toward AI and growth initiatives.

Watch List (8)

  • FedEx Freight Separation
    👁

    Monitor Form 10 registration statement progress and potential disruption to business relationships, spin-off timeline uncertain

  • Wyndham Hotels & Resorts CEO Health
    👁

    CEO Ballotti's multiple myeloma treatment and travel reduction, watch for any operational impact or further disclosures

  • FDA decision on miv-cel for stiff person syndrome, new CFO transition, and commercialization readiness

  • SVP Sales retirement and 6-month consulting transition, monitor for any sales execution impact or further executive changes

  • Shareholder vote on 1M option grant to Executive Chairman by August 17, 2026, potential dilution event on April 1, 2028 vesting

  • 👁

    Monitor shareholder activism following low say-on-pay support (78.6%) and director dissent, next earnings call for compensation changes

  • Watch for further shareholder dissent on equity plans, 2026 Stock Plan 24% opposition may lead to proxy advisor recommendations

  • Monitor director departure details and any subsequent governance disclosures, high risk flag

Filing Analyses (44)
Hilton Worldwide Holdings Inc. 8-K neutral materiality 3/10

18-05-2026

Hilton Worldwide Holdings Inc. filed an 8-K on May 18, 2026, covering Items 5.02 (officer/director changes and compensatory arrangements) and 5.07 (shareholder vote results). Specific details on the individuals involved or vote outcomes are not provided in the available filing metadata, preventing a directional assessment. Without the actual filing text, no positive or negative metrics can be extracted.

  • · Filing date: May 18, 2026, suggests event(s) occurred shortly before (typically within 4 business days).
  • · Presence of both Item 5.02 and Item 5.07 indicates the filing covers both a leadership/compensation change and a shareholder meeting outcome.
  • · No details on who was appointed or resigned; no vote tallies; no compensation amounts.
WYNDHAM HOTELS & RESORTS, INC. 8-K mixed materiality 7/10

18-05-2026

Wyndham Hotels & Resorts CEO Geoff Ballotti disclosed his diagnosis of Multiple Myeloma, a treatable form of bone cancer, which was caught early. He stated his prognosis is favorable and that he will continue working largely as usual while reducing travel, with the full support of the Board. The company reaffirmed its strong start to the year and confidence in delivering value to stakeholders.

  • · Geoff Ballotti has been with Wyndham for nearly 20 years.
  • · His diagnosis followed two months of chest and back pain initially attributed to an exercise injury.
  • · Treatment has begun at Beth Israel/Dana-Farber in Boston, one of the world's leading cancer centers.
  • · The Board was notified last week and supports the CEO's continued engagement with reduced travel.
NEXTERA ENERGY INC 8-K neutral materiality 6/10

18-05-2026

Armando Pimentel, Jr., CEO of Florida Power & Light (FPL) and named executive officer of NextEra Energy, resigned from his FPL CEO role effective May 18, 2026, and was appointed Vice Chairman of NextEra Energy. Scott Bores, currently President of FPL, succeeds him as CEO of FPL, effective the same date. The changes are part of a planned leadership succession process.

  • · Armando Pimentel, Jr. resigned as CEO of FPL and was appointed Vice Chairman of NEE, both effective May 18, 2026.
  • · Scott Bores, previously President of FPL, was appointed CEO of FPL effective May 18, 2026.
  • · The filing is signed by Charles E. Sieving on behalf of both registrants (NEE and FPL).
VIAVI SOLUTIONS INC. 8-K neutral materiality 2/10

18-05-2026

VIAVI Solutions announced a routine rotation of its Audit Committee chair, with independent director Joanne Solomon replacing Donald Colvin effective May 12, 2026, as part of board refreshment and succession planning. Additionally, independent director Doug Gilstrap was appointed to the Corporate Development Committee. No disagreements were involved in these changes.

  • · Donald Colvin will continue to serve as an independent member of the Board and Audit Committee.
  • · Joanne Solomon has served as an independent director since February 2022 and qualifies as an 'audit committee financial expert' under Regulation S-K.
  • · Doug Gilstrap joined the Board in November 2022 and also serves on the Compensation Committee.
PRICE T ROWE GROUP INC 8-K positive materiality 7/10

18-05-2026

T. Rowe Price announced leadership appointments to advance strategy and innovation. Eric Veiel becomes President effective June 1 while retaining co-head of Global Investments and CIO roles; Sébastien Page becomes co-head of Global Investments and CIO; Wyatt Lee will head Global Multi-Asset effective October 1. The firm reported $1.83 trillion in client assets as of April 30, 2026, with about two-thirds retirement-related.

  • · Eric Veiel has been with T. Rowe Price for more than 20 years.
  • · Sébastien Page has 25 years of investment experience.
  • · Wyatt Lee has over 30 years of investment experience and joined the firm in 1999.
  • · Wyatt Lee will be appointed to the Management Committee effective January 1, 2027.
  • · Sébastien Page will remain acting head of Global Multi-Asset through September 30.
  • · About two-thirds of the $1.83 trillion AUM are retirement-related.
FedEx Freight Holding Company, Inc. 8-K neutral materiality 3/10

18-05-2026

FedEx Freight Holding Company, Inc. filed an 8-K under Item 5.02, including cautionary forward-looking statements regarding its planned tax-free separation of the FedEx Freight business into a new publicly traded company. The filing was signed by C. Edward Klank III as President, though no specific officer departure or election details were provided in the content.

  • · The filing date is May 18, 2026, with an event date of May 14, 2026.
  • · The forward-looking statements include risks such as potential uncertainty during the pendency of the separation, possibility the separation will not be completed on time or at all, and potential disruption to existing business relationships.
  • · The filing references a Registration Statement on Form 10 filed in connection with the separation.
VISHAY INTERTECHNOLOGY INC 8-K neutral materiality 3/10

18-05-2026

The filing is an SEC Form 8-K filed by Vishay Intertechnology Inc. on May 18, 2026, covering Items 5.02 (departure/appointment of officers), 5.07 (submission of matters to vote), 8.01 (other events), and 9.01 (financial statements and exhibits). However, the filing summary provided contains no specific details on the nature of the officer change, the individuals involved, or any quantitative data. Without access to the full filing text, no actionable information can be extracted.

Inspired Entertainment, Inc. 8-K neutral materiality 5/10

18-05-2026

Inspired Entertainment announced the departure of James Richardson as EVP and CFO, effective May 14, 2026, and the promotion of Craig Wilson, previously VP of Finance and Accounting, to the role. Wilson will assume responsibilities immediately, and Richardson will remain available for a three-month transition. The filing includes no financial results or performance metrics.

  • · Craig Wilson joined Inspired in 2025 as VP of Finance and Accounting.
  • · Prior to Inspired, Wilson spent six years at Charles River Laboratories as Director of Accounting and Global Consolidations.
  • · Wilson was Financial Controller, International Corporate at Walgreens Boots Alliance from 2014 to 2019.
  • · Wilson holds a BA in accounting from Napier University and is a chartered accountant with ICAS (certified 2013).
AiXin Life International, Inc. 8-K neutral materiality 5/10

18-05-2026

AiXin Life International announced the resignation of Xinliang Li (Christopher Lee) from its Board of Directors effective May 18, 2026. Mr. Lee served as Chair of the Audit Committee and as a member of the Compensation Committee and Nominating and Corporate Governance Committee. The resignation was not due to any disagreement with the company on matters relating to operations, policies, or practices.

  • · The company provided a copy of this Form 8-K to Mr. Lee prior to filing with the SEC.
  • · The company is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.
  • · Mr. Lee's resignation was not due to any disagreement with the company.
FEDEX CORP 8-K neutral materiality 3/10

18-05-2026

FedEx Corporation announced the resignation of Guy M. Erwin II, Corporate Vice President and Chief Accounting Officer, effective May 31, 2026, to join FedEx Freight Holding Company as Senior Vice President – Chief Accounting Officer. The resignation is not due to any disagreement with the company. Claude F. Russ, currently Enterprise Vice President, Finance and recently named Interim Chief Financial Officer effective June 1, 2026, will serve as Interim Chief Accounting Officer effective June 1, 2026, until a permanent successor is appointed.

  • · Mr. Erwin will continue in his current role until May 31, 2026.
  • · Mr. Russ has served as Enterprise Vice President, Finance since June 2024 and previously held various senior roles at FedEx Dataworks and FedEx Freight.
  • · No family relationship between Mr. Russ and any director or executive officer, and no transactions subject to Item 404(a) of Regulation S-K.
Cellectar Biosciences, Inc. 8-K neutral materiality 4/10

18-05-2026

Cellectar Biosciences announced that director Stefan D. Loren, Ph.D. will not stand for reelection at the 2026 annual meeting and will instead serve as a consultant for one year starting July 8, 2026, receiving $15,000 per quarter and a stock option grant of 15,000 shares. Separately, the company appointed Andrew Gu, designated by Nantahala Capital Management, to the board as a Class III director and Audit Committee member, effective May 18, 2026. No disagreements were cited regarding Loren's departure.

  • · Stefan Loren's consulting term is one year, effective July 8, 2026, with options exercisable for 10 years from grant dates.
  • · Andrew Gu holds a B.S. in Economics (Finance) and B.A. in Neuroscience from University of Pennsylvania, Vagelos Life Sciences and Management Program, and has been an analyst at Nantahala since June 2021.
  • · The Board Designation Side Letter requires Nantahala's designee to be appointed no later than June 5, 2026.
  • · The company previously entered into a securities purchase agreement on May 4, 2026 with institutional investors (not detailed in this filing).
MediaAlpha, Inc. 8-K positive materiality 6/10

18-05-2026

MediaAlpha, Inc. announced the appointment of Lauren StClair to its Board of Directors effective May 15, 2026. Ms. StClair brings over 20 years of technology finance leadership, currently serving as CFO of Slice Technologies and previously as CFO of NerdWallet and senior finance roles at eBay. She will also join the Audit Committee.

  • · Ms. StClair holds a Bachelor of Science from Stanford University and an MBA from Duke University's Fuqua School of Business.
  • · MediaAlpha operates with more than 1,150 active partners and generated over 141 million Consumer Referrals in 2025.
  • · Ms. StClair has over 20 years of finance leadership at technology and digital-commerce companies.
  • · Prior to Slice Technologies, she spent more than four years as CFO of NerdWallet (Nasdaq: NRDS).
  • · Her earlier career includes 13 years at eBay in roles such as CFO of eBay North America and CFO/Interim GM of StubHub International.
  • · The appointment is effective May 15, 2026, and Ms. StClair will also serve on the Audit Committee.
Builders FirstSource, Inc. 8-K neutral materiality 5/10

18-05-2026

Builders FirstSource announced a planned leadership succession: Mike Hiller appointed COO-Designate to succeed Steve Herron, who will retire on December 31, 2026. Additionally, Coley O'Brien was appointed Chief Human Resources Officer, succeeding Hiller. The transitions are part of a planned succession to ensure continuity and leverage internal and external talent.

  • · Steve Herron joined Builders FirstSource through the 2015 acquisition of ProBuild Holdings and has over 40 years of industry experience.
  • · Mike Hiller previously served as Vice President of BMC's Intermountain Region before the 2021 merger, later became President of the Central Division, and most recently was Chief Talent Officer.
  • · Coley O'Brien joins from The Wendy's Company, where he served as Chief People Officer since 2007 leading global HR strategy.
  • · Builders FirstSource is headquartered in Irving, Texas, operates ~570 locations across 43 states, and serves 48 of the top 50 CBSAs.
CVS HEALTH Corp 8-K neutral materiality 0/10

18-05-2026

The filing indicates a Form 8-K covering Items 5.02 (Officer/Board changes) and 5.07 (Shareholder vote) for CVS Health Corp on May 18, 2026. However, the actual filing text is not provided, so no specific individuals, positions, or voting outcomes can be extracted. Without the filing content, no actionable analysis is possible.

Penguin Solutions, Inc. 8-K positive materiality 5/10

18-05-2026

Penguin Solutions appointed David Heard, President of Network Infrastructure at Nokia, to its board of directors, effective May 18, 2026. Heard brings over three decades of experience in scaling technology infrastructure, optical networking, and global operations. The appointment is intended to strengthen the company's AI Factory Platform strategy as enterprises accelerate adoption of inference and agentic AI workloads. No financial data or performance metrics were disclosed in the filing.

  • · David Heard joined Nokia in February 2025 following its acquisition of Infinera, where he served as CEO.
  • · Heard holds a Master of Science in Management as a Sloan Fellow from Stanford Graduate School of Business, an MBA from University of Dayton, and a BA in Production and Operations Management from Ohio State University.
  • · He previously served on Infinera's board from November 2020 to February 2025 and currently serves on the Max M. Fisher College of Business Alumni Board.
  • · The press release includes standard forward-looking statements and risk factors related to the company's growth strategy.
POWERDYNE INTERNATIONAL, INC. 8-K materiality 6/10

18-05-2026

Innoviva, Inc. 8-K neutral materiality 5/10

18-05-2026

On May 12, 2026, directors Derek Small and Mark DiPaolo resigned from Innoviva's board to focus on Syndeio BioSciences (a company Innoviva has invested in), with no disagreement related to Innoviva's operations. On May 18, 2026, the board elected Josephine Linden as a new independent director; she will receive initial equity awards totaling $331,250 in restricted stock units and options for 9,166 shares. The changes are part of normal governance adjustments and do not indicate any negative performance trends.

  • · The resignations were to allow Messrs. Small and DiPaolo to focus on the growth of Syndeio BioSciences, a company in which Innoviva has made a series of investments.
  • · Josephine Linden was a Partner and Managing Director at Goldman Sachs for over 25 years and holds an MBA from the University of Chicago.
  • · Linden is expected to serve on the Board's Audit Committee and qualifies as an independent director under SEC and Nasdaq rules.
  • · The Initial RSU Award vests in equal annual installments over two years; the Prorated Annual RSU Award and Option vest in a single installment at the earlier of the next annual meeting or one year from the effective date.
  • · All unvested RSUs and options will immediately vest upon death, disability, or a change in control of the company.
O REILLY AUTOMOTIVE INC 8-K neutral materiality 5/10

18-05-2026

O'Reilly Automotive held its 2026 Annual Meeting on May 14, 2026, where all nine director nominees were elected, including Executive Chairman Greg Henslee. The Board also approved a $2,000,000 stock option award for Henslee vesting over four years. Shareholders approved advisory NEO compensation and ratified Ernst & Young as auditors, but voted against a shareholder proposal on political spending. Notably, director John R. Murphy received substantial against votes of 78.2M, though still elected.

  • · Stock option award for Henslee has exercise price equal to closing price on grant date, vests 25% annually over four years, expires in 10 years.
  • · Among directors, John R. Murphy received the highest against votes: 78,226,419 (13.2% of votes cast excluding broker non-votes), while Maria A. Sastre received the fewest against: 5,012,735.
  • · Shareholder proposal on political spending was defeated with 369,391,768 votes against vs 292,670,896 for; 7,748,205 abstentions and 71,176,543 broker non-votes.
  • · Advisory approval of NEO compensation passed with 613,777,069 for, 53,995,103 against.
  • · Ratification of Ernst & Young as auditor passed with 695,116,311 for, 45,241,655 against.
  • · Board committees (Audit, Compensation, Governance) remain unchanged.
Limbach Holdings, Inc. 8-K positive materiality 6/10

18-05-2026

Limbach Holdings announced the appointment of Michael Reed to the newly created position of Executive Vice President and Chief Operating Officer, effective May 18, 2026. Reed, a 7-year veteran of the company, most recently served as SVP Midwest Regional Manager and previously led integration of acquisitions including Consolidated Mechanical and Pioneer Power. The move aims to strengthen operational execution, support scalable growth, and drive a high-performance culture across the organization's 21 offices and 1,600 team members.

  • · Michael Reed joined Limbach in 2019 as Vice President, Branch Manager.
  • · Subsequent roles included Vice President of Operational Risk Management, Senior Vice President Integrations Leader (2024), and Senior Vice President Midwest Regional Manager (May 2025).
  • · As COO, Reed will oversee both organic growth and strategic acquisitions, as well as culture and employee engagement.
  • · The COO position is newly created, indicating a structural expansion of the executive team.
60 DEGREES PHARMACEUTICALS, INC. 8-K positive materiality 6/10

18-05-2026

On May 13, 2026, 60 Degrees Pharmaceuticals appointed Eric Francois to its Board of Directors, effective immediately. Francois is a seasoned healthcare and life sciences executive with over 20 years of experience, including roles as Managing Director at Raymond James and Credit Suisse, CFO of SCYNEXIS, and independent director roles. He will receive standard non-employee director compensation.

  • · There are no arrangements or understandings between Mr. Francois and any other persons pursuant to which he was appointed as a director.
  • · There are no family relationships between Mr. Francois and any director or executive officer of the Company.
  • · Mr. Francois has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
  • · Mr. Francois will receive compensation for his service on the Board consistent with the Company’s standard compensation arrangements for non-employee directors.
NACCO INDUSTRIES INC 8-K positive materiality 6/10

18-05-2026

NACCO Industries held its annual meeting on May 15, 2026, approving the Amended and Restated Long-Term Executive Compensation Plan, which increases the authorized share pool to 800,000 shares and extends the plan term to March 1, 2036. Stockholders also elected all 11 director nominees and ratified Ernst & Young as auditor, with say-on-pay frequency set to annual. Key executives, including the CEO, received target awards for 2026 totaling over $5.7 million, though the plan caps annual payouts at $12 million per participant.

  • · The Amended Plan replaced the previous plan (approved in 2023) and was effective March 1, 2026, with stockholder approval obtained on May 15, 2026.
  • · Non-Executive Director Group target awards for 2026 are $0 under the plan.
  • · Say-on-pay advisory proposal received 99.7% support (20,071,173 votes for), and the board set future say-on-pay votes to occur every year.
  • · Broker non-votes were 440,344 on all director and compensation-related proposals.
  • · The plan caps annual payout per participant at the greater of $12 million or fair market value of 500,000 award shares.
LendingTree, Inc. 8-K neutral materiality 4/10

18-05-2026

LendingTree, Inc. announced the departure of Chief Human Resources Officer Jill Olmstead without cause, effective May 31, 2026. She will receive severance benefits under the Executive Severance Pay Plan, including cash equal to 1.0x base salary paid over 12 months, accelerated vesting of equity awards that would vest within 12 months, and 12 months of COBRA premium reimbursement. Additionally, she will enter a consulting agreement from June 1, 2026 to March 31, 2027, receiving $10,000 per month for up to 80 hours of transition services, with continuous service treatment under the 2023 Stock Plan to qualify for Retirement vesting treatment.

  • · Jill Olmstead's employment termination without cause is effective May 31, 2026.
  • · Severance includes cash equal to 1.0x base salary (amount not disclosed) paid over 12 months.
  • · Accelerated vesting applies only to equity awards that would have vested during the 12 months following termination.
  • · COBRA premium reimbursement covers 12 months for Olmstead and eligible dependents.
  • · Consulting period runs from June 1, 2026 to March 31, 2027 (10 months).
  • · Continuous service treatment under the 2023 Stock Plan allows Olmstead to satisfy the 'Rule of 65' for retirement eligibility, enabling continued vesting of certain equity awards.
ON SEMICONDUCTOR CORP 8-K neutral materiality 5/10

18-05-2026

onsemi held its 2026 Annual Meeting on May 14, 2026, electing seven directors and approving all proposals, including advisory say-on-pay, ratification of PricewaterhouseCoopers as auditor, and a simple majority voting stockholder proposal. However, Simon Keeton's final employment day was extended to September 30, 2026 to support an orderly transition, and several directors received notable opposition votes (e.g., Christine Yan with 26.2M votes against).

  • · Simon Keeton's final day of employment extended from expected June 30, 2026 to September 30, 2026 for orderly transition.
  • · All seven director nominees elected with varying levels of support; the lowest support was Christine Y. Yan with 315,466,839 votes for and 26,206,130 against.
  • · Advisory say-on-pay passed with 320,342,318 votes for (93.7% of votes cast excluding broker non-votes).
  • · Ratification of PricewaterhouseCoopers as auditor passed with 337,232,526 votes for (93.4% of votes cast).
  • · Stockholder proposal for simple majority voting approved with 333,533,083 votes for (98.9% of votes cast excluding broker non-votes).
Medtronic plc 8-K neutral materiality 5/10

18-05-2026

Medtronic announced that Brett Wall will depart as Executive Vice President and President, Neuroscience Portfolio, effective June 1, 2026. Dr. Kweli Thompson, currently Senior Vice President and President, Cardiac Rhythm Management, will assume that role on the same date. Wall will remain an employee until September 1, 2026 to assist with the transition and will receive severance per the company's executive severance practices.

  • · Wall will assist with the transition until September 1, 2026.
  • · Severance terms are consistent with Medtronic's executive severance practices as disclosed in the 2025 Proxy Statement (filed August 25, 2025).
  • · The change is effective June 1, 2026.
ASHLAND INC. 8-K positive materiality 4/10

18-05-2026

Ashland Inc. appointed Bertrand Loy, executive chair of Entegris Inc., to its board of directors effective May 15, 2026. Loy will serve on the audit and governance and nominating committees, and the board size increases to nine members. The appointment is part of Ashland's strategy to drive scalable growth.

  • · Appointment effective May 15, 2026
  • · Loy serves on audit and governance and nominating committees
  • · Board size increased to nine members in anticipation of potential director retirements
ASPEN AEROGELS INC 8-K neutral materiality 0/10

18-05-2026

This Form 8-K filed on May 18, 2026, reports items related to officer/director changes (Item 5.02), shareholder vote results (Item 5.07), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details about the nature of the leadership changes, vote outcomes, or other material terms are available from the provided metadata. Without the actual filing text, a substantive analysis of the officer change or its implications cannot be performed.

  • · Filing date: May 18, 2026
  • · File size: 239 KB
  • · Sector not specified
  • · No specific officer names, titles, or actions (appointment/resignation) are disclosed in the provided metadata.
ALTRIA GROUP, INC. 8-K materiality 6/10

18-05-2026

Macy's, Inc. 8-K mixed materiality 5/10

18-05-2026

At the May 15, 2026 annual meeting, Macy's shareholders approved all proposals including the election of 10 directors, ratification of KPMG as auditor, advisory say-on-pay, and an amendment to the 2024 Equity and Incentive Compensation Plan. However, the say-on-pay proposal received only 78.6% support (157.7M for vs 43.0M against), and director Deirdre Connelly received the lowest support among nominees at 77.5% of votes cast, indicating notable shareholder dissent. The compensation plan amendment passed with 92% support.

FLAGSTAR BANK, NATIONAL ASSOCIATION 8-K positive materiality 7/10

18-05-2026

Flagstar Bank, N.A. announced a one-year extension of CEO Joseph Otting's employment agreement through March 2028, reflecting board confidence in his leadership and the bank's return to profitability. Richard Raffetto and Lee Smith were appointed Co-Presidents and Co-Chief Operating Officers with expanded responsibilities, while Bao Nguyen became Chief Legal Officer and COO/COO for Consumer and Retail Banking, Sydney Menefee became Chief Audit Executive, and Peter Sullivan became General Counsel. The bank reported $87.1B in assets, $60.7B in loans, $66.8B in deposits, and $8.1B equity as of March 31, 2026.

  • · Otting relinquishes the title of President but remains Executive Chairman and CEO.
  • · Raffetto will lead all commercial lending, relationship banking, commercial real estate, consumer banking, and private banking.
  • · Smith retains CFO role and adds oversight of human resources, information technology, and operations.
  • · Nguyen will oversee strategic planning, regulatory affairs, and community investment functions.
  • · Menefee will transition to Chief Audit Executive by end of June, reporting to Audit Committee Chair and CEO.
  • · Sullivan assumes day-to-day management of the legal department as General Counsel.
MARRIOTT VACATIONS WORLDWIDE Corp 8-K mixed materiality 5/10

18-05-2026

At the 2026 annual meeting held on May 15, 2026, Marriott Vacations Worldwide Corp stockholders elected all nine director nominees, ratified Ernst & Young as independent auditors (99.6% for), and approved advisory say-on-pay (97.6% for). However, the approval of the Second Amended Equity Incentive Plan (extending the term to 2036 and adding 2.5M shares) received only 68.9% support from votes cast (excluding broker non-votes), with 31.0% against, indicating notable shareholder dissent.

  • · The annual meeting had 29,969,049 shares represented (approximately 87% of shares entitled to vote).
  • · All nine director nominees were elected with 'for' votes ranging from 24,883,586 to 25,221,440; broker non-votes were 4,661,773 for each.
  • · Ratification of Ernst & Young as independent auditors received 29,837,885 for, 118,109 against, 13,055 abstain.
  • · Advisory say-on-pay received 24,701,685 for, 553,458 against, 52,133 abstain, with 4,661,773 broker non-votes.
  • · The Second Amended Plan extends the plan term to May 15, 2036, adds 2,500,000 shares, and modifies treatment under golden parachute tax provisions (Sections 280G and 4999).
  • · The Company's Common Stock ($0.01 par value) trades under the symbol VAC on the NYSE.
FENNEC PHARMACEUTICALS INC. 8-K neutral materiality 3/10

18-05-2026

Fennec Pharmaceuticals announced inducement stock option grants to three new non-executive employees under its 2026 Equity Inducement Plan, approved by the Compensation Committee on May 11, 2026. The options cover 50,000 shares at an exercise price of $9.75 per share, vesting one-third after one year and monthly thereafter over 24 months. The grants comply with Nasdaq Listing Rule 5635(c)(4) as material inducements for employment.

  • · The stock options have a ten-year term from the grant date of May 18, 2026.
  • · The exercise price of $9.75 per share equals the closing price on The Nasdaq Capital Market on March 15, 2026.
  • · Vesting schedule: one-third of shares vest on the one-year anniversary, then monthly over the following 24 months, contingent on continued employment.
MiniMed Group, Inc. 8-K neutral materiality 3/10

18-05-2026

On May 17, 2026, Brett Wall, a class II director of MiniMed Group, Inc., notified the Board of his resignation effective July 3, 2026, due to his departure as Executive Vice President and President, Neuroscience Portfolio at Medtronic plc, MiniMed's parent company. The resignation is not due to any disagreement. On May 18, 2026, Scott Cundy, Senior Vice President and Chief Quality, Development, and Innovation Officer at Medtronic, was appointed to fill the vacancy, effective July 3, 2026, as a class II director with a term expiring at the 2027 annual meeting. Mr. Cundy will receive no compensation while Medtronic is an affiliate.

  • · Brett Wall served as a class II director and member of the Nominating and Corporate Governance Committee.
  • · Scott Cundy will serve on the same committee and his term expires at the 2027 annual meeting of stockholders.
  • · Cundy leads Global Quality, Product Development, and Innovation at Medtronic and is a member of the Medtronic Executive Committee.
  • · Cundy previously held a role at Danaher Corporation and holds a B.S. from Georgia Tech and an MBA from the University of Minnesota.
  • · No material interest in any transaction requiring disclosure under Item 404(a) of Regulation S-K.
  • · Cundy will receive no compensation for board service as long as Medtronic is an affiliate; thereafter compensation will be consistent with other non-employee directors per MiniMed's March 9, 2026 Form 8-K.
Eagle Bancorp Montana, Inc. 8-K positive materiality 6/10

18-05-2026

Eagle Bancorp Montana, Inc. (EBMT) announced the appointment of P. Darryl Rensmon, currently EVP and COO, as President effective June 1, 2026, as part of long-term succession planning. Laura F. Clark will remain CEO until her future retirement, with the Board splitting the CEO and President roles. The transition aims to ensure smooth leadership continuity and leverage Rensmon's operational expertise.

  • · Rensmon joined Eagle in September 2016 as Vice President/Chief Information Officer and was promoted to Senior Vice President in October 2017, then to SVP/COO in October 2022, and EVP in April 2025.
  • · Rensmon holds a BS in Business Administration - Information Systems Management from Montana State University-Billings and is a 2021 graduate of the Stonier Graduate School of Banking and the Wharton Leadership Program.
  • · Rensmon previously served as Vice President/Chief Information Officer for Morrison-Maierle, Inc. and President of Morrison-Maierle Systems Corp.
  • · Opportunity Bank of Montana operates 30 banking offices and was established in 1922.
Kyverna Therapeutics, Inc. 8-K positive materiality 7/10

18-05-2026

Kyverna Therapeutics appointed Greg Martini as Chief Financial Officer, effective May 18, 2026, succeeding Dr. Marc Grasso who will consult during the transition. Martini joins from Ironwood Pharmaceuticals where he served as SVP and CFO, leading capital allocation and supporting commercial expansion. The company granted him an inducement option to purchase 325,000 shares. This leadership change comes as Kyverna advances its lead CAR T-cell therapy candidate miv-cel toward potential approval for stiff person syndrome and prepares for commercialization.

  • · Greg Martini previously served as SVP and CFO of Ironwood Pharmaceuticals, where he helped drive positive EBITDA and cash flow growth while achieving significant operational savings.
  • · Prior to Ironwood, Martini held finance and corporate development roles at Thermo Fisher Scientific and positions at Ernst & Young and Raytheon Technologies.
  • · The inducement option vests over four years: 25% after one year, then monthly 1/48th thereafter, subject to continued service.
  • · Kyverna's lead candidate miv-cel has completed a registrational trial in stiff person syndrome and is in an ongoing registrational trial for generalized myasthenia gravis.
  • · The company is also investigating miv-cel in multiple sclerosis and rheumatoid arthritis through investigator-initiated trials.
Xponential Fitness, Inc. 8-K positive materiality 5/10

18-05-2026

Xponential Fitness appointed Danielle Porto Parra as President, effective May 18, 2026. Parra brings over 20 years of leadership experience across franchise systems and Fortune 100 companies, most recently as President and Chief Brand Officer of McAlister's Deli. CEO Mr. Nuzzo expressed confidence in her ability to enhance unit-level economics and franchisee partnerships, though the filing contains no financial metrics or performance data to assess the appointment's impact.

  • · Danielle Porto Parra previously served as President and Chief Brand Officer of McAlister's Deli.
  • · She led Marketing & Culinary Innovation at GoTo Foods across brands including Cinnabon, Auntie Anne's, and Jamba.
  • · Her experience spans Fortune 100 companies, private equity-backed organizations, franchise systems, and entrepreneurial high-growth businesses.
  • · Xponential Fitness franchises five brands: Club Pilates, StretchLab, YogaSix, Pure Barre, and BFT.
  • · The Company has franchise agreements in 49 U.S. states, Puerto Rico, and 28 additional countries.
Tri-State Generation & Transmission Association, Inc. 8-K neutral materiality 3/10

18-05-2026

Tri-State Generation & Transmission Association announced that its member Mountain View Electric Association elected James Riggins to replace Rick Gordon as its representative on the Board of Directors, effective June 4, 2026. Mr. Riggins will serve on the External Affairs-Member Relations Committee. No financial or operational impact is expected from this board change.

  • · The election was certified on May 14, 2026 and filed on May 18, 2026.
  • · James Riggins will serve on the External Affairs-Member Relations Committee.
  • · The change is effective June 4, 2026.
Mastech Digital, Inc. 8-K positive materiality 6/10

18-05-2026

At its annual meeting on May 13, 2026, Mastech Digital shareholders approved an amendment to the Stock Incentive Plan to allow restricted stock units (92.8% for), elected two Class III directors (Arun Nayar with 94.0% for, Srinivas Kandula with 93.3% for), and passed a non-binding advisory vote on executive compensation (92.2% for). However, approximately 7.1% voted against the RSU amendment and 7.7% voted against the say-on-pay resolution, indicating some shareholder dissent.

  • · The proxy statement detailing the amendment was filed with the SEC on April 9, 2026.
  • · The Stock Incentive Plan had previously been amended on May 14, 2024 and May 14, 2025.
  • · The advisory vote on executive compensation (Proposal 3) is non-binding on the company.
  • · All proposals had zero broker non-votes.
  • · The 8-K was filed on May 18, 2026, with a report date of May 13, 2026.
Ultragenyx Pharmaceutical Inc. 8-K positive materiality 6/10

18-05-2026

Ultragenyx Pharmaceutical Inc. held its 2026 Annual Meeting on May 14, 2026, 2026, where stockholders elected three Class I directors (Emil D. Kakkis, Shehnaaz Suliman, Daniel G. Welch), approved the Third Amended and Restated 2023 Incentive Plan, ratified Ernst & Young as independent auditor, and approved executive compensation on an advisory basis. All proposals passed with majority support, though the incentive plan received a notable 22.9 million votes against.

  • · Broker non-votes totaled 11,211,890 on director elections and proposals 1, 2, and 4.
  • · The Third A&R 2023 Plan received 50,659,150 votes for and 22,888,600 votes against, with 26,748 abstentions.
  • · Ratification of Ernst & Young as independent auditor passed with 84,551,399 votes for, 221,802 against, and 13,187 abstentions.
  • · Advisory vote on executive compensation received 70,945,277 votes for, 2,594,517 against, and 34,704 abstentions.
  • · The annual meeting was held on May 14, 2026, with record date March 23, 2026.
Envoy Medical, Inc. 8-K neutral materiality 5/10

18-05-2026

Envoy Medical, Inc. held its 2026 Annual Meeting on May 12, 2026, where stockholders approved amendments to the 2023 Equity Incentive Plan (adding 6,000,000 shares) and the 2023 Employee Stock Purchase Plan (adding 1,200,000 shares). Directors Brent T. Lucas and Susan J. Kantor were elected, and EisnerAmper LLP was ratified as independent auditor. All proposals passed with strong majority support, reflecting routine governance and no dissent on compensation or share authorization.

  • · Brent T. Lucas received 47,216,205 votes for and 70,530 withheld; Susan J. Kantor received 46,961,571 for and 325,164 withheld.
  • · Ratification of EisnerAmper: 47,933,597 for, 3,434 against, 5,670 abstain.
  • · Advisory vote on executive compensation: 47,144,585 for, 110,476 against, 31,674 abstain, with 655,966 broker non-votes.
  • · Equity Plan Amendment: 46,609,864 for, 624,758 against, 52,113 abstain, with 655,966 broker non-votes.
  • · ESPP Amendment: 47,152,146 for, 86,804 against, 47,785 abstain, with 655,966 broker non-votes.
  • · Warrant issuance approval: 47,217,476.89 for, 42,625 against, 26,634 abstain, with 655,966 broker non-votes.
LQR House Inc. 8-K neutral materiality 5/10

18-05-2026

LQR House Inc. disclosed the resignation of board member Kah Loong Randy Yeo effective May 12, 2026, with no reported disagreements. Effective May 18, 2026, Hong Chun (Alan) Yeung was appointed Chair of the Audit Committee and Yuting (Tina) Luo was appointed Chair of the Nominating and Corporate Governance Committee, resulting in a reduction of the board size from seven to six directors.

  • · The board was reduced from seven to six directors following the resignation.
Celcuity Inc. 8-K mixed materiality 6/10

18-05-2026

Celcuity Inc. held its 2026 Annual Meeting on May 14, 2026. Stockholders approved the 2026 Stock Incentive Plan authorizing 3,000,000 new shares and the Amended and Restated 2017 Employee Stock Purchase Plan adding 289,199 shares with a 10-year extension. Eight directors were elected, and the appointment of Boulay PLLP as auditor was ratified. However, the 2026 Plan received significant opposition with about 24% of votes cast against, indicating notable shareholder dissent.

  • · Director voting results showed significant withheld votes: David F. Dalvey received 5,788,089 withheld (15.4% of votes cast), while Lance G. Laing, Richard J. Nigon, and Charles R. Romp each had over 99% support.
  • · Ratification of Boulay PLLP as auditor passed with 40,931,291 for, 377,611 against, and 19,865 abstain (no broker non-votes).
  • · Advisory vote on executive compensation passed with 35,835,588 for and 1,846,980 against (4.9% against).
  • · No director departures or officer changes were reported; the filing covers only the annual meeting vote results.
Super Micro Computer, Inc. 8-K neutral materiality 4/10

18-05-2026

Don Clegg, SVP of Worldwide Sales, announced his retirement from Super Micro Computer, Inc., effective May 15, 2026. The departure is not due to any disagreement with the company. To ensure a smooth transition, Mr. Clegg entered into a 6-month consulting agreement at $19,450 per month starting May 16, 2026.

  • · Don Clegg's resignation is not the result of any disagreement with the company's operations, policies, or procedures.
  • · The consulting agreement is effective May 16, 2026, with a term of 6 months at $19,450 per month.
Hour Loop, Inc 8-K neutral materiality 7/10

18-05-2026

Hour Loop, Inc. entered into Addendum No. 7 to the employment agreements of CEO/Chairman Sam Lai and Senior VP/Director Maggie Yu, revising their 2026 bonus structures. Each executive will receive a bonus of 50% of base salary if net profits (excluding taxes and executive bonuses) reach $1M, or 100% of base salary if net profits reach $2M, with only one bonus determinations made at year-end. Additionally, each is guaranteed a $100,000 bonus payable on December 22, 2026. Lai and Yu, who are husband and wife, collectively own approximately 94.8% of the company's voting power.

  • · The addenda are the seventh amendments to the respective executive employment agreements.
  • · Only one of the two performance-based bonuses (50% or 100% of base salary) will be payable per executive if conditions are met.
  • · The guaranteed $100,000 bonus for each executive is payable on December 22, 2026, regardless of profit targets.
  • · Lai and Yu are husband and wife; each is deemed to indirectly beneficially own the other's 16,680,071 shares, resulting in identical beneficial ownership of 33,360,142 shares each.
  • · The filing includes Exhibits 10.1 and 10.2 (the addenda) and a cover page interactive data file.
LESAKA TECHNOLOGIES INC 8-K neutral materiality 6/10

18-05-2026

Lesaka Technologies Inc. (LSAK) announced an amendment to the employment agreement of Executive Chairman Ali Mazanderani, extending it from January 31, 2028 to June 30, 2029. He will continue to receive a base salary of $600,000 per annum without short-term cash incentives. Additionally, a new South African employment contract was approved effective July 1, 2026 to June 30, 2029, with an annual base salary of ZAR 5,000,000 and travel expenses up to ZAR 4,000,000 per financial year. The Board also granted an option to purchase 1,000,000 shares at $5.00 per share, subject to shareholder approval by August 17, 2026, vesting contingent on employment through April 1, 2028.

  • · The stock option may only be exercised during the period from April 1, 2029 to April 1, 2030.
  • · Vesting of the stock option requires Mr. Mazanderani's continuous employment as Executive Chair through April 1, 2028.
  • · Shareholder approval for the option grant must be obtained by no later than August 17, 2026.
  • · The SA Employment Contract is with the wholly owned subsidiary Lesaka Technologies Proprietary Limited and includes customary terms and conditions.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 44 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Executive Officer Management Changes SEC

🇺🇸 More from United States

View all →